Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


PEAR Therapeutics
745 Atlantic Ave.
Boston, MA 02111
Phone: 646-932-2774
https://peartherapeutics.com/

PEAR Therapeutics is the leader in FDA-cleared prescription digital therapeutics. The company's approach is to integrate clinically-validated software applications with previously approved pharmaceuticals and treatment paradigms to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. PEAR's lead product, reSET, is an FDA-cleared 12-week interval prescription therapeutic for Substance Use Disorder (SUD) to be used as an adjunct to standard, outpatient treatment. PEAR's product development pipeline includes reSET-O™ for opioid use disorder (OUD) and additional prescription digital therapeutics in schizophrenia (THRIVE™), combat post-traumatic stress disorder (reCALL™), general anxiety disorder (reVIVE™), pain, major depressive order, and insomnia, for which PEAR intends to obtain FDA clearance.

Key Contact
NameTitleE-Mail
Corey McCannCEOcorey@peartherapeutics.com


Funding Events
DateAmountTypeInvestors
01/02/18$50,000,000Series B 5AM Ventures
Arboretum Ventures
Bridge Builders Collaborative
EDBI
Jazz Venture Partners
Novartis Venture Funds
Temasek  
01/04/19$64,000,000Series C 5AM Ventures
Arboretum Ventures
Blue Water Life Science Fund
Bridge Builders Collaborative
EDBI
Jazz Venture Partners
Novartis Venture Funds  
Temasek
Trustbridge Partners
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.